89. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Freitag, 14. April 2023 (Posterbereich 13) 10:00-11:30

Postervorträge

TAVI – Biomarker

Diskussionsleitung: C. Piper (Bad Oeynhausen), J. Wöhrle (Friedrichshafen)

(P1317) Prognostic Impact and Proteomic Biomarkers of Frailty in Severe Aortic Stenosis and TAVI
    B. E. Beuthner, C. F. Jacob, P. Bengel, M. El Kenani, K. Toischer, G. Hasenfuß, M. Schnelle, M. Puls (Göttingen)
(P1318) Biomarkers to predict outcomes after surgical aortic valve replacement or repair
    T. J. Demal, J. Bialczak, A. Goßling, F. M. Ojeda, O. Bhadra, M. Linder, S. Ludwig, D. Grundmann, L. Voigtländer-Buschmann, L. Waldschmidt, J. Schirmer, N. Schofer, S. Blankenberg, H. Reichenspurner, L. Conradi, M. Seiffert, A. Schäfer (Hamburg)
(P1319) Evaluation of tubular markers as prognostic markers for acute kidney injury in dependence of plasma volume status in patients with contrast medium exposure and severe aortic valve stenosis
    A. Schober, C. Heidel, N. Roth, C. M. Xu, M. Schlossbauer, U. Hubauer, A. Schober, M. Schober, L. S. Maier, A. Luchner, C. G. Jungbauer, K. Debl (Regensburg)
(P1320) Evaluation of N-acetyl-ß-D-glucosaminidase and kidney injury molecule-1 as prognostic markers for acute kidney injury in patients with severe aortic valve stenosis and TAVR
    A. Schober, C. Heidel, N. Roth, C. M. Xu, A. Schober, M. Schober, U. Hubauer, M. Schlossbauer, A. Luchner, L. S. Maier, K. Debl, C. G. Jungbauer (Regensburg)
(P1321) Circulating microRNA-122-5p is associated with a lack of improvement in left-ventricular function after TAVR and regulates viability of cardiomyocytes via extracellular vesicles
    M. R. Hosen, P. R. Goody, A. Zietzer, S. T. Niepmann, A. Sedaghat, V. Tiyerili, J.-M. Sinning, S. Zimmer, S. Uchida, J. B. Moore IV, R. Boon, R. Chennupati, E. Latz, N. Werner, F. Jansen, G. Nickenig (Bonn, Dortmund, Köln, Düsseldorf, Trier; Copenhagen, DK; Louisville, US; Amsterdam, NL)
(P1322) Different phenotyping of monocytes between severe aortic stenosis patients undergoing surgical valve replacement or transcatheter aortic valve implantation
    C. Langnau, N. Göbel, S. Gekeler, I. I. Müller, K.-P. Kreißelmeier, O. Borst, D. Rath, M. Droppa, T. Geisler, U. Franke, M. Radwan, C. Schlensak, H. Janning, T. Castor, S. Autenrieth, M. Gawaz, K. A. L. Müller (Tübingen, Stuttgart, Heidelberg)
(P1323) The long noncoding RNA HIF1a-AS1 regulates endothelial cell function and augments in patients with aortic valve disease with coronary artery disease
    L. Zhou, Y. Zhou, K. Maus, P. Düsing, A. Zietzer, P. R. Goody, S. Zimmer, F. Jansen, G. Nickenig, M. R. Hosen (Bonn)
(P1324) Fast progressive aortic stenosis is associated with specific pro-inflammatory monocyte phenotypes
    K. A. L. Müller, C. Langnau, T. Harm, M. Sigle, M. Ilg, A.-K. Rohlfing, N. Goebel, U. Franke, M. Radwan, C. Schlensak, H. Janning, D. Rath, K.-P. Kreisselmeier, T. Castor, I. I. Müller, S. E. Autenrieth, M. Gawaz (Tübingen, Stuttgart, Heidelberg)